Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$1.39 - $2.21 $28,526 - $45,355
-20,523 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$1.27 - $3.42 $4,451 - $11,987
3,505 Added 20.6%
20,523 $40,000
Q4 2020

Feb 09, 2021

SELL
$0.94 - $1.89 $4,984 - $10,022
-5,303 Reduced 23.76%
17,018 $21,000
Q3 2020

Nov 13, 2020

BUY
$1.5 - $9.38 $2,596 - $16,236
1,731 Added 8.41%
22,321 $40,000
Q2 2020

Aug 03, 2020

BUY
$4.79 - $8.39 $37,812 - $66,230
7,894 Added 62.18%
20,590 $173,000
Q1 2020

May 15, 2020

SELL
$3.44 - $7.21 $32,112 - $67,305
-9,335 Reduced 42.37%
12,696 $67,000
Q4 2019

Feb 12, 2020

SELL
$4.29 - $5.64 $9,579 - $12,594
-2,233 Reduced 9.2%
22,031 $120,000
Q3 2019

Nov 12, 2019

SELL
$4.87 - $7.08 $1,719 - $2,499
-353 Reduced 1.43%
24,264 $118,000
Q2 2019

Aug 13, 2019

SELL
$6.6 - $7.8 $17,219 - $20,350
-2,609 Reduced 9.58%
24,617 $171,000
Q1 2019

May 15, 2019

BUY
$5.76 - $8.95 $14,808 - $23,010
2,571 Added 10.43%
27,226 $189,000
Q4 2018

Feb 14, 2019

SELL
$5.26 - $7.97 $25,121 - $38,064
-4,776 Reduced 16.23%
24,655 $144,000
Q3 2018

Nov 14, 2018

SELL
$4.65 - $7.95 $5,366 - $9,174
-1,154 Reduced 3.77%
29,431 $222,000
Q2 2018

Aug 13, 2018

SELL
$5.05 - $6.8 $7,075 - $9,526
-1,401 Reduced 4.38%
30,585 $154,000
Q1 2018

May 14, 2018

SELL
$5.6 - $9.25 $26,712 - $44,122
-4,770 Reduced 12.98%
31,986 $195,000
Q4 2017

Feb 14, 2018

BUY
$6.6 - $7.78 $242,589 - $285,961
36,756
36,756 $261,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.